SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001870913-23-000016
Filing Date
2023-11-20
Accepted
2023-11-20 20:58:10
Documents
1
Period of Report
2023-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1700531880.html 4/A  
1 FORM 4/A wk-form4a_1700531880.xml 4/A 7734
  Complete submission text file 0001870913-23-000016.txt   9306
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address
Shanmugam Muthusamy (Reporting) CIK: 0001870913 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-31812 | Film No.: 231424255